These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 34167889)
41. Acute Kidney Injury and Renal Replacement Therapy in Critically Ill COVID-19 Patients: Risk Factors and Outcomes: A Single-Center Experience in Brazil. Doher MP; Torres de Carvalho FR; Scherer PF; Matsui TN; Ammirati AL; Caldin da Silva B; Barbeiro BG; Carneiro FD; Corrêa TD; Ferraz LJR; Dos Santos BFC; Pereira VG; Batista MC; Monte JCM; Santos OFP; Bellomo R; Serpa Neto A; Durão MS Blood Purif; 2021; 50(4-5):520-530. PubMed ID: 33341806 [TBL] [Abstract][Full Text] [Related]
42. A retrospective audit of insulin infusion management involving a locally developed dynamic insulin infusion guideline in a tertiary ICU. Breeding J; Welch S; Buscher H; Nair P; Frost C; Newman S; Whittam S Aust Crit Care; 2015 Aug; 28(3):149-59. PubMed ID: 25092627 [TBL] [Abstract][Full Text] [Related]
43. A phase II randomised controlled trial of intensive insulin therapy in general intensive care patients. Mitchell I; Knight E; Gissane J; Tamhane R; Kolli R; Leditschke IA; Bellomo R; Finfer S; Crit Care Resusc; 2006 Dec; 8(4):289-93. PubMed ID: 17227263 [TBL] [Abstract][Full Text] [Related]
44. Bolus administration of intravenous glucose in the treatment of hyperkalemia: a randomized controlled trial. Chothia MY; Halperin ML; Rensburg MA; Hassan MS; Davids MR Nephron Physiol; 2014; 126(1):1-8. PubMed ID: 24576893 [TBL] [Abstract][Full Text] [Related]
45. Observational study of the relative efficacy of insulin-glucose treatment for hyperkalaemia in patients with liver cirrhosis. Lim AKH; Crnobrnja L; Metlapalli M; Jiang C; Wang RSH; Pham JH; Abasszade JH BMJ Open; 2021 Oct; 11(10):e051201. PubMed ID: 34686554 [TBL] [Abstract][Full Text] [Related]
46. Impact of glycemic variability and hypoglycemia on adverse hospital outcomes in non-critically ill patients. Kim Y; Rajan KB; Sims SA; Wroblewski KE; Reutrakul S Diabetes Res Clin Pract; 2014 Mar; 103(3):437-43. PubMed ID: 24456994 [TBL] [Abstract][Full Text] [Related]
47. Intensive insulin therapy for patients in paediatric intensive care: a prospective, randomised controlled study. Vlasselaers D; Milants I; Desmet L; Wouters PJ; Vanhorebeek I; van den Heuvel I; Mesotten D; Casaer MP; Meyfroidt G; Ingels C; Muller J; Van Cromphaut S; Schetz M; Van den Berghe G Lancet; 2009 Feb; 373(9663):547-56. PubMed ID: 19176240 [TBL] [Abstract][Full Text] [Related]
48. Effect of a Standardized Treatment Panel on Hypoglycemic Events in Hospitalized Acute Hyperkalemic Patients Treated With Intravenous Regular Insulin. Zuern A; Probst LA; Darko W; Rosher P; Miller CD; Gordon L; Seabury R Hosp Pharm; 2020 Aug; 55(4):240-245. PubMed ID: 32742012 [No Abstract] [Full Text] [Related]
49. Safety and efficacy of an intensive insulin protocol in a burn-trauma intensive care unit. Cochran A; Davis L; Morris SE; Saffle JR J Burn Care Res; 2008; 29(1):187-91. PubMed ID: 18182920 [TBL] [Abstract][Full Text] [Related]
50. Validation of an insulin infusion nomogram for intensive glucose control in critically ill patients. Chant C; Wilson G; Friedrich JO Pharmacotherapy; 2005 Mar; 25(3):352-9. PubMed ID: 15843282 [TBL] [Abstract][Full Text] [Related]
51. Higher insulin infusion rate but not 24-h insulin consumption is associated with hypoglycemia in critically ill patients. Radosevich JJ; Patanwala AE; Frey PD; Lee YG; Paddock H; Erstad BL Diabetes Res Clin Pract; 2015 Dec; 110(3):322-7. PubMed ID: 26489824 [TBL] [Abstract][Full Text] [Related]
52. Association Between the Use of Long-Acting Insulin and Hypoglycemia in Nondiabetic Patients in the Surgical Intensive Care Unit. Masse J; Giuliano CA; Brown S; Paxton RA J Intensive Care Med; 2018 May; 33(5):317-321. PubMed ID: 27821581 [TBL] [Abstract][Full Text] [Related]
53. Incidence and outcome of contrast-associated acute kidney injury assessed with Risk, Injury, Failure, Loss, and End-stage kidney disease (RIFLE) criteria in critically ill patients of medical and surgical intensive care units: a retrospective study. Kim MH; Koh SO; Kim EJ; Cho JS; Na SW BMC Anesthesiol; 2015; 15():23. PubMed ID: 25780349 [TBL] [Abstract][Full Text] [Related]
54. Safety of a Nurse-Driven Standardized Potassium Replacement Protocol in Critically Ill Patients With Renal Insufficiency. Conley R; Rich RL; Montero J Crit Care Nurse; 2021 Apr; 41(2):e10-e16. PubMed ID: 33791770 [TBL] [Abstract][Full Text] [Related]
55. Long-term safety and efficacy of sodium zirconium cyclosilicate for hyperkalaemia in patients with mild/moderate versus severe/end-stage chronic kidney disease: comparative results from an open-label, Phase 3 study. Roger SD; Lavin PT; Lerma EV; McCullough PA; Butler J; Spinowitz BS; von Haehling S; Kosiborod M; Zhao J; Fishbane S; Packham DK Nephrol Dial Transplant; 2021 Jan; 36(1):137-150. PubMed ID: 32030422 [TBL] [Abstract][Full Text] [Related]
56. Risk factors for hypoglycaemia in neurocritical care patients. van Iersel FM; Slooter AJ; Vroegop R; Wolters AE; Tiemessen CA; Rösken RH; van der Hoeven JG; Peelen LM; Hoedemaekers CW Intensive Care Med; 2012 Dec; 38(12):1999-2006. PubMed ID: 22907674 [TBL] [Abstract][Full Text] [Related]
57. Evaluating the risk of hyperkalaemia and acute kidney injury with cotrimoxazole: a retrospective observational study. Rajput J; Moore LSP; Mughal N; Hughes S Clin Microbiol Infect; 2020 Dec; 26(12):1651-1657. PubMed ID: 32220637 [TBL] [Abstract][Full Text] [Related]
58. Achieving durable glucose control in the intensive care unit without hypoglycaemia: a new practical IV insulin protocol. Balkin M; Mascioli C; Smith V; Alnachawati H; Mehrishi S; Saydain G; Slone H; Alessandrini J; Brown L Diabetes Metab Res Rev; 2007 Jan; 23(1):49-55. PubMed ID: 16874843 [TBL] [Abstract][Full Text] [Related]
59. Incidence, Risk Factors, and Outcome of Acute Kidney Injury in Neurocritical Care. Büttner S; Stadler A; Mayer C; Patyna S; Betz C; Senft C; Geiger H; Jung O; Finkelmeier F J Intensive Care Med; 2020 Apr; 35(4):338-346. PubMed ID: 29378487 [TBL] [Abstract][Full Text] [Related]
60. Weight-Based Insulin During and After Intravenous Insulin Infusion Reduces Rates of Rebound Hyperglycemia When Transitioning to Subcutaneous Insulin in the Medical Intensive Care Unit. Zhou K; Buehler LA; Zaw T; Bena J; Lansang MC Endocr Pract; 2022 Feb; 28(2):173-178. PubMed ID: 34687910 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]